Martina A. Sersch, M.D., Ph.D., has been appointed chief medical officer, Mustang Bio, Inc. Dr. Sersch will oversee the clinical development of Mustang’s pipeline in CAR T technology and gene therapies. Dr. Sersch has more than 17 years of experience in early- and late-stage clinical development in academia and industry, with specialty training in oncology, infectious and tropical diseases. Prior to joining Mustang, Dr. Sersch served as executive director at Amgen, where she successfully led ...